195 related articles for article (PubMed ID: 26421585)
1. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients.
Mulder RL; Paulides M; Langer T; Kremer LC; van Dalen EC
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD006300. PubMed ID: 26421585
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients.
Mulder RL; Paulides M; Langer T; Kremer LC; van Dalen EC
Cochrane Database Syst Rev; 2012 Dec; 12():CD006300. PubMed ID: 23235629
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients.
Mulder RL; Paulides M; Langer T; Kremer LC; van Dalen EC
Cochrane Database Syst Rev; 2010 Feb; (2):CD006300. PubMed ID: 20166081
[TBL] [Abstract][Full Text] [Related]
4. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
[TBL] [Abstract][Full Text] [Related]
5. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
van Dalen EC; Raphaël MF; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2014 Sep; (9):CD006647. PubMed ID: 25188452
[TBL] [Abstract][Full Text] [Related]
6. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate for high-grade osteosarcoma in children and young adults.
van Dalen EC; de Camargo B
Cochrane Database Syst Rev; 2009 Jan; (1):CD006325. PubMed ID: 19160278
[TBL] [Abstract][Full Text] [Related]
8. High-dose ifosfamide as second- or third-line chemotherapy in refractory bone and soft tissue sarcoma patients.
Lee SH; Chang MH; Baek KK; Han B; Lim T; Lee J; Park JO
Oncology; 2011; 80(3-4):257-61. PubMed ID: 21734417
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate for high-grade osteosarcoma in children and young adults.
van Dalen EC; van As JW; de Camargo B
Cochrane Database Syst Rev; 2011 May; 2011(5):CD006325. PubMed ID: 21563152
[TBL] [Abstract][Full Text] [Related]
10. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
van Dalen EC; Raphaël MF; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2009 Jan; (1):CD006647. PubMed ID: 19160293
[TBL] [Abstract][Full Text] [Related]
11. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
van Dalen EC; Raphaël MF; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2011 Jan; (1):CD006647. PubMed ID: 21249679
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group.
Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Verweij J; Dombernowsky P; Onsrud M; Thomas D; Sylvester R
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S180-4. PubMed ID: 8453694
[TBL] [Abstract][Full Text] [Related]
13. Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients.
van Oosterom AT; Mouridsen HT; Nielsen OS; Dombernowsky P; Krzemieniecki K; Judson I; Svancarova L; Spooner D; Hermans C; Van Glabbeke M; Verweij J;
Eur J Cancer; 2002 Dec; 38(18):2397-406. PubMed ID: 12460784
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B; Kremer LC; Caron HN; van Dalen EC
Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
[TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma.
Haveman LM; van Ewijk R; van Dalen EC; Breunis WB; Kremer LC; van den Berg H; Dirksen U; Merks JH
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011405. PubMed ID: 34472082
[TBL] [Abstract][Full Text] [Related]
16. High-dose ifosfamide in the treatment of sarcomas of soft tissues and bone.
Demetri GD
Semin Oncol; 1996 Jun; 23(3 Suppl 6):22-6. PubMed ID: 8677444
[TBL] [Abstract][Full Text] [Related]
17. Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma Group.
Blackledge G; Steward WP; Verweij J; Mouridsen H; Bramwell V; Schütte J; van Oosterom A; Dombernowsky P; Buesa J; Van Glabekke M
Semin Oncol; 1992 Feb; 19(1 Suppl 1):14-8. PubMed ID: 1411615
[TBL] [Abstract][Full Text] [Related]
18. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY
Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437
[TBL] [Abstract][Full Text] [Related]
20. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.
van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD006247. PubMed ID: 27107610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]